Página 4 - Melhores Imunohistoquímica médicos - TOP-92 médicos

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

O médico é chefe do Departamento de Hematologia do Centro Médico Hadassah e professor especializado em diagnóstico molecular de doenças hematológicas, doenças malignas do sangue, transplante de medula óssea, terapia genética e imunologia. Após se formar na Faculdade de Medicina da Universidade Ben-Gurion do Negev, o médico completou estudos de pós-graduação no Memorial Sloan-Kettering Cancer Center. Em 2017, o médico tornou-se a primeira mulher a servir como Reitora da Escola de Medicina Hadassah. O médico é membro de várias sociedades profissionais, incluindo a Sociedade Israelense de Hematologia e a Sociedade Internacional de Hemato-Oncologia.<\/p>

Com 20 anos de prática, a médica se especializa em hematologia e oncologia pediátrica, focando em doenças raras de câncer de sangue. Ela realizou mais de 3.500 transplantes de medula óssea, ganhando uma reputação entre os pacientes como aquela que "transplanta vida."

Sua expertise e dedicação foram reconhecidas pela Forbes, que a nomeou uma das melhores médicas em 2018.

O médico formou-se na Escola de Medicina de Hacettepe em 1985 e tornou-se Especialista em Medicina Interna na Universidade de Ege em 1990. Aprofundando sua expertise, o médico especializou-se em hematologia e completou um doutorado na Escola de Medicina de Mie no Japão em 1995. Em 1997, o médico avançou para Professor Assistente e depois Professor de Hematologia na Universidade de Ege. Em 2003, o médico continuou como Professor de Hematologia na Universidade Técnica de Karadeniz. Com mais de 65 artigos científicos, 112 trabalhos em reuniões e 34 apresentações em conferências, o médico é reconhecido por suas contribuições à hematologia e ao transplante de medula óssea.<\/p>

Education

• Undergraduate: Istanbul Faculty of Medicine, Istanbul University, 2007
• MSc (Internal Medicine Department): Marmara University Faculty of Medicine, 2012
• PhD (Hematology Clinic): Istanbul Training and Research Hospital, 2018
• Associate Professor (Hematology Clinic): Prof.Dr.Cemil Tascioglu Training and Research Hospital, 2019

Prof. Dr. Rafet Eren graduated from Istanbul Faculty of Medicine in 2007. He completed his Internal Medicine specialty training at Marmara University Faculty of Medicine in 2012. In 2018, he became a Hematology subspecialist at Istanbul Training and Research Hospital. In 2019, he was awarded the title of Associate Professor in the field of Hematology. Afterwards, he worked as a faculty member at Başakşehir Çam and Sakura City Hospital, Bozyaka Training and Research Hospital and Istinye University (Istinye University Bahçeşehir and Liv Hospital Vadistanbul) and is currently working at Biruni University Hospital. Dr. Rafet Eren is a member of Turkish Society of Hematology, Hematology Specialty Society and European Society of Hematology and speaks English fluently. He has around 50 publications in national and international refereed journals.

Scientific Memberships

• Turkish Hematology Association
• Hematology Specialty Society
• Turkish Internal Medicine Specialty Society
• European Society of Hematology
•  

Awards 

• Young Researcher Award (42nd National Hematology Congress), 2016
• Special Jury Paper Award (3rd Hematologic Oncology Congress), 2015
• Paper 3rd Prize (2nd Hematologic Oncology and Bone Marrow Transplantation Symposium), 2016

Education

• Faculty of Medicine: Trakya University, 1982-1988
• Radiation Oncology Residency: Şişli Etfal Training and Research Hospital, 1994-1998
• Radiation Oncology Residency: Princess Margaret Hospital Toronto, 1996
• Phytotherapy Master's Degree: Istanbul University Faculty of Pharmacy, 2017-2018

Experience

• Professor, Head of Department: Health Sciences University Bursa Faculty of Medicine, Department of Radiation Oncology, 2021-2024
• Professor, Head of Department: Health Sciences University Izmir Faculty of Medicine, Department of Radiation Oncology, 2021-2024
• Professor: Department of Radiation Oncology, Health Sciences University Istanbul Hamidiye Faculty of Medicine, 2021-2024
• Lecturer Gelisim University SMYO, 2013-2020

Medical Interests

• Breast Cancer / Intraoperative Radiotherapy
• Gynaecological Cancers / Brachytherapy Applications
• Gastrointestinal System Tumours
• Prostate Cancer / Hydrogel Space Oar Certificate and Application
• Lung Cancers
• Brain Tumours
• Head and Neck Cancers

Education

Istanbul University Cerrahpaşa Faculty of Medicine, 2002
Istanbul Fatih Sultan Mehmet Training and Research Hospital, Internal Medicine, 2010
Istanbul University Oncology Institute (Çapa), Medical Oncology, 2015
Medipol University Faculty of Medicine, Phytotherapy Education, 2018
University of Health Sciences, Vocational School of Health, Molecular Oncology, PhD Program, PhD, 2023

Experience

University Hospital, Newark, New Jersey, USA, Observer (2003-2004)
Siirt State Hospital, Internal Medicine (2010-2011)
Siirt State Hospital, Medical Oncology (2015)
Bakırköy Dr. Sadi Konuk Training and Research Hospital, Medical Oncology (2015-2018)
Istanbul University, Istanbul Faculty of Medicine, Department of Internal Medicine, Medical Oncology, (Professor Doctor) (2018-Present)
Forensic Medicine 3. Specialization Board, Medical Oncology, Full Member (2019-Present)
Liv Hospital, Ulus, Park-time, Medical Oncology (2020-2022)
Şişli Kolan International Hospital, Park-time, Medical Oncology (2022-2023)

Medical Intrests

• Gastrointestinal System Tumours (Esophagus - Stomach and Large Bowel Cancer)
• Hepatobiliary System Tumours (Liver-Biliary Tract and Pancreatic Cancer)
• Breast Cancer
• Lung Cancer
• Genitourinary Cancers
• Immunotherapies and Target Therapies
• Molecular Oncology
• Immunotherapies
• Target Treatments
•  

Awards

2010-YDUS (Subspecialty Examination) 14th place in Turkey
2014- Oncology Institute Days Best Poster Award
2015- Turkish Medical Oncology Society Board Exam Qualification
2015- ESMO (European Society for Medical Oncology) Board Exam Qualification

Dr. Hilmi Apak is a respected pediatric hematology-oncology specialist with more than 21 years of experience. He is trained in pediatric oncology. Dr. Apak has led advanced treatments, including bone marrow transplantation, leukemia chemotherapy, and CAR T-cell therapy.

He has published 75 international medical articles, showing his strong contribution to pediatric oncology research. Dr. Apak has worked as assistant editor for the Turkish Pediatrics Archives Periodical. He has also held important academic and leadership positions, such as Head of Pediatric Hematology-Oncology at Istanbul University-Cerrahpaşa.

O médico completou a formação de especialização em Oncologia de Radiação na Faculdade de Medicina da Universidade de Marmara de 2012 a 2016. Antes disso, o médico completou uma graduação em Medicina, ministrada em inglês, na mesma instituição de 2004 a 2011. O médico tem uma sólida base em educação médica, começando com a educação secundária na Escola Número Dezesseis de Shirvan no Azerbaijão de 1998 a 2004.<\/p>

O médico formou-se na Faculdade de Medicina da Universidade de Ancara em 1992 e tornou-se Especialista em Medicina na Faculdade de Medicina da Universidade Uludağ, Departamento de Doenças Infantis. Em 2002, o médico serviu como Professor Assistente em Hematologia Pediátrica na mesma instituição.<\/p>

O médico é especializado no diagnóstico e tratamento de cânceres infantis, leucemia (linfoma), doenças hemorrágicas infantis, oclusão vascular, tratamentos de anemia e deficiências de ferro e vitaminas.<\/p>

Com uma forte formação acadêmica, o médico publicou 15 artigos em revistas internacionais com revisão por pares, apresentou 9 textos completos em reuniões científicas internacionais, foi autor de 3 livros ou capítulos de livros e publicou 8 artigos em revistas locais com revisão por pares.<\/p>

Prof. Dr. Osman İLHAN graduated from Ankara University Faculty of Medicine in 1978. After completing his internal medicine residency at the same faculty in 1982, he served as a senior resident at the GATA Hematology Clinic during his military service. After completing his mandatory service at SSK Ulus Hospital, he returned to Ankara University Faculty of Medicine for a subspecialty. In 1990, he became an associate professor of hematology. He worked in Genoa, Italy to increase his knowledge and experience in leukemia. He was part of the team that performed the first bone marrow stem cell transplant in Turkey. In 1996, he went to the MD Anderson Cancer Center in the USA to work on "Stem Cell Mobilization, Cryopreservation, and Transplantation." In 1996, he became a professor of hematology. In 1999, he was elected as the regional president of ESFH (European Society for Hemapheresis). Dr. İlhan, who was the founder and president of the Hemapheresis Society in 2000, joined the World Apheresis Association (WAA) in 2001. He became the President of the Turkish Hematology Association in October 2001. Dr. İlhan, who is an active member of the European Hematology Association (EHA), was a member of the accreditation committee (ECAH) for education. He played a role in the accreditation of Turkish hematologists in CME credits by participating in the accreditation of congresses and courses held in Turkey as a Provider Status. He served as the founding president of the Cellular Therapy and Regenerative Medicine Association established in 2008. He became the founding president of the Geriatric Hematology Association in 2011. He is the Honorary President of the World Apheresis Congress (WAA) held in 2012. Dr. İlhan, who previously served on drug licensing and ethics committees at the Ministry of Health, has also served as the Chairman of the Photopheresis-Apheresis Commission and the Scientific Committee for Bone Marrow Transplantation, as well as the Chairman of the National Organ Tissue Cell Coordination Board, the Scientific Board of Cord Blood, and the Stem Cell Research Board. He is the founding president of the STEM CELL FOUNDATION and has played an important role in the establishment of TURKOK (Turkish Stem Cell Donor Bank). Dr. İlhan has over 300 publications in journals registered in PubMed and more than 5000 citations. He holds the Platinum CME certificate from the European Hematology Association. He owns four brands/patents named “Kökten Çözüm (Deep Solution), Telehematoloji (Telehematology), Hemaferez (Hemapheresis), Kanser Kök Hücresi (Cancer Stem Cell)”. He is currently the President of the Ankara Medical Association. Prof. Dr. Osman İlhan, who served at Ankara University Faculty of Medicine for 50 years, began working at Özel Koru Ankara Hospital as of January 1, 2023.

His medical interests include:

Hematopoietic Stem Cell Transplantation (Autologous, Allogeneic)

Acute Leukemia

Chronic Leukemia Treatments

Hodgkin Lymphoma

Non-Hodgkin Lymphoma Treatments

Multiple Myeloma Treatments, MDS

Aplastic Anemia

ITP

TTP Treatments

Hypercoagulability

Hereditary Thrombophilia Treatments

Therapeutic Apheresis

Photopheresis

Geriatric Hematology Diseases.

O médico é um especialista experiente em hematologia oncológica infantil e um neurocirurgião pediátrico líder na Espanha. Com mais de 30 anos de experiência prática, o médico lidera a Unidade de Hematologia e Oncologia Pediátrica no HM Hospitales, focando em doenças hematológicas e cancerígenas graves em crianças e adolescentes.<\/p>

O médico é especializado no diagnóstico e tratamento de distúrbios hematológicos e cancerígenos, particularmente nos sistemas eritrocitário, mieloide e linfoide. O médico atua como consultor da OMS e da UNESCO e está envolvido em atividades de ensino e pesquisa.<\/p>

As credenciais educacionais incluem diplomas da Universidad Complutense de Madrid, da Universidade de Barcelona e da Universidade de Maryland.<\/p>

O médico completou um MD em Medicina Interna no Shyam Shah Medical College e realizou uma Residência Sênior no mesmo departamento. Após isso, o médico atuou como Registrador em Oncologia Médica no Hospital de Câncer Jawaharlal Nehru. O médico completou o treinamento DNB em Oncologia Médica no Hospital Indraprastha Apollo.<\/p>

Durante a Residência Sênior, o médico lecionou na Escola Internacional de Inverno de Oncologia no AIIMS e apresentou pesquisa sobre Câncer de Estômago no Simpósio de Câncer Gastrointestinal da Sociedade Americana de Oncologia Clínica. O médico se especializa na base molecular do câncer e terapias direcionadas.<\/p>

O médico recebeu treinamento em Oncologia Cirúrgica no Tata Memorial Hospital, Mumbai, e completou o MRCS no Royal College of Surgeons, Edimburgo. Iniciando a prática em 2000, o médico fundou o Curie Manavata Cancer Centre em 2007. Com 19 anos de experiência, o médico realizou mais de 50.000 cirurgias de câncer e participou de mais de 200 ensaios clínicos. O médico é autor publicado com numerosas publicações internacionais e nacionais. Especializando-se em Oncologia Cirúrgica de Mama e Torácica, o médico é professor de DNB Superspecialty Surgical Oncology e Breast Surgery na MUHS.<\/p>

Dr. Itir Sirinoglu Temiz is a Professor of Hematology. She specializes in lymphoma, acute and chronic leukemias, multiple myeloma, thrombocytopenias, thrombosis, anemia, and bone marrow failure. She graduated with honors from Istanbul University Cerrahpaşa Faculty of Medicine. She completed her hematology training at Dr. Abdurrahman Yurtarslan Oncology Education and Research Hospital.

Dr. Sirinoglu Temiz has held key academic and administrative positions. She served as Head of Internal Medicine at IAU Faculty of Medicine. She was also Education and Administrative Manager at SBÜ Bakırköy Dr. Sadi Konuk EAH Hematology Clinic. She has broad experience in adult hematology, stem cell transplantation, and therapeutic apheresis. She currently practices at Liv Hospital.

O médico completou um MBBS na MIMER, Pune, e um MS na GMC Panaji. O treinamento adicional incluiu uma bolsa de dois anos em Oncologia Cirúrgica no Tata Medical Centre, Kolkata, com foco em Câncer Gastrointestinal. No Tata Medical Center, o médico atuou como Co-investigador Principal em vários projetos de pesquisa originais. Após isso, o médico trabalhou como Professor Assistente no Instituto Estadual do Câncer e no Hospital do Câncer do Governo, Aurangabad. Com mais de 10 anos de experiência, o médico realizou com sucesso mais de 10.000 cirurgias de grande porte e publicou vários artigos Nacionais e Internacionais. Especializa-se em Cirurgias de Câncer Minimamente Invasivas.<\/p>

O médico formou-se na Faculdade de Medicina da Universidade de Uludağ com um Diploma de Medicina em 1983 e completou uma residência em Oncologia Radioterápica no Centro de Oncologia e Medicina Nuclear em Istambul em 1990. Uma bolsa de pós-doutorado em Termoradioterapia foi concluída na Universidade Thomas Jefferson de 1990 a 1994. O médico atuou como Professor e Presidente do Departamento de Oncologia Radioterápica na Faculdade de Medicina da Universidade de Uludağ de 1994 a 2005 e foi o Coordenador de Acreditação da Faculdade de 2001 a 2004.<\/p>

De 2004 a 2017, o médico foi Professor e Diretor do Departamento de Oncologia Radioterápica no Centro Médico Anadolu, também servindo como Coordenador de Ciências Oncológicas de 2011 a 2017. Atualmente, o médico é o Diretor de Ciências Oncológicas no Hospital Medicana Bursa, posição que ocupa desde 2018.<\/p>